Matulionė, J. 2022. FIRST-LINE TREATMENT WITH PEMBROLIZUMAB PLUS CHEMOTHERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER WITHOUT TUMOR PD-L1 EXPRESSION. Pulmonology and allergology. 6, 2 (Oct. 2022), 232-237. DOI:https://doi.org/10.37499/PIA.1027.